Esperion Therapeutics (ESPR) Q1 2025 Earnings Call May 06, 2025 08:00 AM ET Company Participants Alina Venezia - Head of Investor RelationsSheldon Koenig - President & CEOBen Halladay - CFOJason Zemansky - Vice President, Equity Research, Biotechnology and PharmaceuticalsBetty Swartz - Chief Business Officer Conference Call Participants Dennis Ding - Vice President - Equity Research AnalystJoseph Pantginis - MD & Senior Healthcare AnalystKristen Kluska - Equity Research AnalystSerge Belanger - Senior Analys ...

Esperion Therapeutics (ESPR) Q1 2025 Earnings Call May 06, 2025 08:00 AM ET Speaker0 Ladies and gentlemen, thank you for standing by and welcome. At this time, all participants are in a listen only mode. Following the presentation, there will be a question and answer session. Please be advised that today's conference call will be recorded. I would now like to hand the conference over to Alina Venezia, Director of Investor Relations for Esperion Therapeutics. Please go ahead. Speaker1 Thank you, operator. Go ...

Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q4 2024 Earnings Conference Call March 4, 2025 8:00 AM ET Company Participants Alina Venezia - Director of Investor Relations Sheldon Koenig - President and Chief Executive Officer Ben Halladay - Chief Financial Officer Eric Warren - Chief Commercial Officer Conference Call Participants Dennis Ding - Jefferies Joseph Pantginis - H.C. Wainwright Thomas Shrader - BTIG Tanmay Patwardhan - JPMorgan Jason Zemansky - Bank of America Serge Belanger - Needham Paul Choi - Go ...